STOCK TITAN

[Form 4] Snowflake Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Negative)
Form Type
4
Rhea-AI Filing Summary

CYCC – Insider Transaction Summary (Form 4, filed 8/4/25)

  • Reporting person: David E. Lazar, previously a ≥10% owner.
  • Transaction: On 07/30/25 Lazar sold 6,750 common shares at $12.36, an aggregate value of roughly $83.4k.
  • Post-sale stake: 155,838 common shares held directly.
  • Reverse split impact: Holdings reflect the 1-for-15 reverse split effected 07/07/25.
  • Exit filing: After this sale Lazar’s ownership fell below the 10% threshold, ending Section 16 insider status.
  • Prior error corrected: A February 28 filing mistakenly listed 354,738 Series D preferred shares that had already converted into 162,588 common shares (post-split).

Investor take-away: The divestiture is modest in absolute terms but material because it removes a former large shareholder from insider reporting requirements, potentially reducing future visibility into his trades. No derivative transactions or option activity were reported.

CYCC – Riepilogo Transazione Insider (Modulo 4, depositato il 4/8/25)

  • Persona che segnala: David E. Lazar, precedentemente proprietario di almeno il 10%.
  • Transazione: Il 30/07/25 Lazar ha venduto 6.750 azioni ordinarie a $12,36 ciascuna, per un valore complessivo di circa $83.400.
  • Quota post-vendita: 155.838 azioni ordinarie detenute direttamente.
  • Impatto del frazionamento inverso: Le partecipazioni riflettono il frazionamento inverso 1-per-15 effettuato il 07/07/25.
  • Dichiarazione di uscita: Dopo questa vendita, la quota di Lazar è scesa sotto la soglia del 10%, terminando lo status di insider ai sensi della Sezione 16.
  • Correzione di errore precedente: Una dichiarazione del 28 febbraio aveva erroneamente indicato 354.738 azioni privilegiate Serie D già convertite in 162.588 azioni ordinarie (post-frazionamento).

Conclusione per gli investitori: La cessione è modesta in termini assoluti ma significativa perché elimina un ex grande azionista dagli obblighi di segnalazione insider, riducendo potenzialmente la visibilità futura sulle sue operazioni. Non sono state segnalate transazioni su strumenti derivati o attività su opzioni.

CYCC – Resumen de Transacción Insider (Formulario 4, presentado el 4/8/25)

  • Persona informante: David E. Lazar, anteriormente propietario de ≥10%.
  • Transacción: El 30/07/25 Lazar vendió 6.750 acciones comunes a $12,36, con un valor total aproximado de $83.400.
  • Participación tras la venta: 155.838 acciones comunes en propiedad directa.
  • Impacto de la división inversa: Las participaciones reflejan la división inversa 1 por 15 realizada el 07/07/25.
  • Declaración de salida: Tras esta venta, la propiedad de Lazar cayó por debajo del umbral del 10%, finalizando su condición de insider bajo la Sección 16.
  • Corrección de error previo: Una presentación del 28 de febrero listó erróneamente 354.738 acciones preferentes Serie D que ya se habían convertido en 162.588 acciones comunes (post-división).

Conclusión para inversores: La desinversión es modesta en términos absolutos pero relevante porque elimina a un ex gran accionista de los requisitos de reporte insider, reduciendo potencialmente la visibilidad futura de sus transacciones. No se reportaron operaciones con derivados ni actividad en opciones.

CYCC – 내부자 거래 요약 (양식 4, 2025년 8월 4일 제출)

  • 보고자: David E. Lazar, 이전에 10% 이상 보유자.
  • 거래 내역: 2025년 7월 30일, Lazar는 6,750 보통주를 주당 $12.36에 매도했으며, 총 가치는 약 $83,400입니다.
  • 매도 후 지분: 직접 보유한 보통주 155,838주.
  • 역병합 영향: 2025년 7월 7일 시행된 1대 15 역병합을 반영한 보유 주식 수입니다.
  • 내부자 지위 종료 신고: 이번 매도로 Lazar의 지분이 10% 미만으로 떨어져 섹션 16 내부자 지위가 종료되었습니다.
  • 이전 오류 수정: 2월 28일 제출된 문서에서 이미 162,588주 보통주(역병합 후)로 전환된 354,738주 시리즈 D 우선주가 잘못 기재된 점을 바로잡았습니다.

투자자 참고 사항: 매도 규모는 절대적으로 크지 않지만, 전 대주주가 내부자 보고 의무에서 제외되어 향후 거래 내역에 대한 가시성이 줄어들 수 있다는 점에서 중요합니다. 파생상품 거래나 옵션 활동은 보고되지 않았습니다.

CYCC – Résumé de la transaction d’initié (Formulaire 4, déposé le 04/08/25)

  • Personne déclarant : David E. Lazar, auparavant détenteur d’au moins 10 %.
  • Transaction : Le 30/07/25, Lazar a vendu 6 750 actions ordinaires à 12,36 $ chacune, pour une valeur totale d’environ 83 400 $.
  • Participation après vente : 155 838 actions ordinaires détenues directement.
  • Impact du regroupement d’actions inversé : Les avoirs tiennent compte du regroupement inversé 1 pour 15 effectué le 07/07/25.
  • Déclaration de sortie : Après cette vente, la participation de Lazar est passée sous le seuil de 10 %, mettant fin à son statut d’initié selon la Section 16.
  • Correction d’une erreur antérieure : Un dépôt du 28 février avait incorrectement listé 354 738 actions préférentielles de série D déjà converties en 162 588 actions ordinaires (post-regroupement).

À retenir pour les investisseurs : La cession est modeste en valeur absolue mais importante car elle retire un ancien actionnaire important des obligations de déclaration des initiés, ce qui pourrait réduire la visibilité future de ses transactions. Aucune transaction sur dérivés ou activité sur options n’a été signalée.

CYCC – Zusammenfassung Insider-Transaktion (Formular 4, eingereicht am 4.8.25)

  • Meldende Person: David E. Lazar, zuvor Eigentümer von ≥10%.
  • Transaktion: Am 30.07.25 verkaufte Lazar 6.750 Stammaktien zu je $12,36, was einem Gesamtwert von etwa $83.400 entspricht.
  • Anteil nach Verkauf: 155.838 direkt gehaltene Stammaktien.
  • Auswirkung der Rückwärtsaktienaufteilung: Bestände spiegeln die 1-zu-15 Rückwärtsaufteilung vom 07.07.25 wider.
  • Ausstiegsmeldung: Nach diesem Verkauf fiel Lazars Anteil unter die 10%-Schwelle, womit der Insider-Status gemäß Abschnitt 16 endet.
  • Korrektur eines früheren Fehlers: Eine Einreichung vom 28. Februar listete fälschlicherweise 354.738 Vorzugsaktien der Serie D, die bereits in 162.588 Stammaktien (nach Aufteilung) umgewandelt wurden.

Fazit für Investoren: Die Veräußerung ist absolut gesehen moderat, aber bedeutsam, da ein ehemaliger Großaktionär nicht mehr den Meldepflichten unterliegt, was die zukünftige Transparenz seiner Transaktionen verringern könnte. Es wurden keine Derivat- oder Optionsgeschäfte gemeldet.

Positive
  • Administrative clarity: Corrects prior share-count error, improving accuracy of insider ownership data.
Negative
  • Insider sale: 6,750 shares disposed at $12.36 signals reduced commitment.
  • Loss of 10% holder status: Investor visibility diminishes as Lazar exits Section 16 reporting.

Insights

TL;DR: Insider sold 6,750 shares, fell below 10% stake, ending reporting duties—signal skews slightly negative.

The sale represents only ~4.1% of Lazar’s post-split holdings, yet the structural implication is larger: he is no longer a statutory insider, limiting future disclosure. While the dollar amount is small, exiting the >10% bracket can suggest waning strategic interest or a planned liquidation path. The filing also cleans up an earlier conversion-count error, improving data integrity. Overall, impact is modest but directionally negative for sentiment, as insider selling and reduced transparency often weigh on micro-cap biotech names like Cyclacel.

CYCC – Riepilogo Transazione Insider (Modulo 4, depositato il 4/8/25)

  • Persona che segnala: David E. Lazar, precedentemente proprietario di almeno il 10%.
  • Transazione: Il 30/07/25 Lazar ha venduto 6.750 azioni ordinarie a $12,36 ciascuna, per un valore complessivo di circa $83.400.
  • Quota post-vendita: 155.838 azioni ordinarie detenute direttamente.
  • Impatto del frazionamento inverso: Le partecipazioni riflettono il frazionamento inverso 1-per-15 effettuato il 07/07/25.
  • Dichiarazione di uscita: Dopo questa vendita, la quota di Lazar è scesa sotto la soglia del 10%, terminando lo status di insider ai sensi della Sezione 16.
  • Correzione di errore precedente: Una dichiarazione del 28 febbraio aveva erroneamente indicato 354.738 azioni privilegiate Serie D già convertite in 162.588 azioni ordinarie (post-frazionamento).

Conclusione per gli investitori: La cessione è modesta in termini assoluti ma significativa perché elimina un ex grande azionista dagli obblighi di segnalazione insider, riducendo potenzialmente la visibilità futura sulle sue operazioni. Non sono state segnalate transazioni su strumenti derivati o attività su opzioni.

CYCC – Resumen de Transacción Insider (Formulario 4, presentado el 4/8/25)

  • Persona informante: David E. Lazar, anteriormente propietario de ≥10%.
  • Transacción: El 30/07/25 Lazar vendió 6.750 acciones comunes a $12,36, con un valor total aproximado de $83.400.
  • Participación tras la venta: 155.838 acciones comunes en propiedad directa.
  • Impacto de la división inversa: Las participaciones reflejan la división inversa 1 por 15 realizada el 07/07/25.
  • Declaración de salida: Tras esta venta, la propiedad de Lazar cayó por debajo del umbral del 10%, finalizando su condición de insider bajo la Sección 16.
  • Corrección de error previo: Una presentación del 28 de febrero listó erróneamente 354.738 acciones preferentes Serie D que ya se habían convertido en 162.588 acciones comunes (post-división).

Conclusión para inversores: La desinversión es modesta en términos absolutos pero relevante porque elimina a un ex gran accionista de los requisitos de reporte insider, reduciendo potencialmente la visibilidad futura de sus transacciones. No se reportaron operaciones con derivados ni actividad en opciones.

CYCC – 내부자 거래 요약 (양식 4, 2025년 8월 4일 제출)

  • 보고자: David E. Lazar, 이전에 10% 이상 보유자.
  • 거래 내역: 2025년 7월 30일, Lazar는 6,750 보통주를 주당 $12.36에 매도했으며, 총 가치는 약 $83,400입니다.
  • 매도 후 지분: 직접 보유한 보통주 155,838주.
  • 역병합 영향: 2025년 7월 7일 시행된 1대 15 역병합을 반영한 보유 주식 수입니다.
  • 내부자 지위 종료 신고: 이번 매도로 Lazar의 지분이 10% 미만으로 떨어져 섹션 16 내부자 지위가 종료되었습니다.
  • 이전 오류 수정: 2월 28일 제출된 문서에서 이미 162,588주 보통주(역병합 후)로 전환된 354,738주 시리즈 D 우선주가 잘못 기재된 점을 바로잡았습니다.

투자자 참고 사항: 매도 규모는 절대적으로 크지 않지만, 전 대주주가 내부자 보고 의무에서 제외되어 향후 거래 내역에 대한 가시성이 줄어들 수 있다는 점에서 중요합니다. 파생상품 거래나 옵션 활동은 보고되지 않았습니다.

CYCC – Résumé de la transaction d’initié (Formulaire 4, déposé le 04/08/25)

  • Personne déclarant : David E. Lazar, auparavant détenteur d’au moins 10 %.
  • Transaction : Le 30/07/25, Lazar a vendu 6 750 actions ordinaires à 12,36 $ chacune, pour une valeur totale d’environ 83 400 $.
  • Participation après vente : 155 838 actions ordinaires détenues directement.
  • Impact du regroupement d’actions inversé : Les avoirs tiennent compte du regroupement inversé 1 pour 15 effectué le 07/07/25.
  • Déclaration de sortie : Après cette vente, la participation de Lazar est passée sous le seuil de 10 %, mettant fin à son statut d’initié selon la Section 16.
  • Correction d’une erreur antérieure : Un dépôt du 28 février avait incorrectement listé 354 738 actions préférentielles de série D déjà converties en 162 588 actions ordinaires (post-regroupement).

À retenir pour les investisseurs : La cession est modeste en valeur absolue mais importante car elle retire un ancien actionnaire important des obligations de déclaration des initiés, ce qui pourrait réduire la visibilité future de ses transactions. Aucune transaction sur dérivés ou activité sur options n’a été signalée.

CYCC – Zusammenfassung Insider-Transaktion (Formular 4, eingereicht am 4.8.25)

  • Meldende Person: David E. Lazar, zuvor Eigentümer von ≥10%.
  • Transaktion: Am 30.07.25 verkaufte Lazar 6.750 Stammaktien zu je $12,36, was einem Gesamtwert von etwa $83.400 entspricht.
  • Anteil nach Verkauf: 155.838 direkt gehaltene Stammaktien.
  • Auswirkung der Rückwärtsaktienaufteilung: Bestände spiegeln die 1-zu-15 Rückwärtsaufteilung vom 07.07.25 wider.
  • Ausstiegsmeldung: Nach diesem Verkauf fiel Lazars Anteil unter die 10%-Schwelle, womit der Insider-Status gemäß Abschnitt 16 endet.
  • Korrektur eines früheren Fehlers: Eine Einreichung vom 28. Februar listete fälschlicherweise 354.738 Vorzugsaktien der Serie D, die bereits in 162.588 Stammaktien (nach Aufteilung) umgewandelt wurden.

Fazit für Investoren: Die Veräußerung ist absolut gesehen moderat, aber bedeutsam, da ein ehemaliger Großaktionär nicht mehr den Meldepflichten unterliegt, was die zukünftige Transparenz seiner Transaktionen verringern könnte. Es wurden keine Derivat- oder Optionsgeschäfte gemeldet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Slootman Frank

(Last) (First) (Middle)
C/O SNOWFLAKE INC.
106 EAST BABCOCK STREET, SUITE 3A

(Street)
BOZEMAN MT 59715

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Snowflake Inc. [ SNOW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/31/2025 M(1) 256,046 A $8.88 421,553(2) D
Common Stock 07/31/2025 S(1) 44,799 D $225.405(3) 376,754(2) D
Common Stock 07/31/2025 S(1) 56,406 D $226.711(4) 320,348(2) D
Common Stock 07/31/2025 S(1) 102,910 D $227.498(5) 217,438(2) D
Common Stock 07/31/2025 S(1) 46,154 D $228.364(6) 171,284(2) D
Common Stock 07/31/2025 S(1) 5,777 D $229.106(7) 165,507(2) D
Common Stock 6,384 I LLC(8)
Common Stock 83,014 I Foundation(9)
Common Stock 335,146 I Trust(10)
Common Stock 250,030 I Trust(11)
Common Stock 91,058 I Trust(12)
Common Stock 91,058 I Trust(13)
Common Stock 16,300 I Trust(14)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $8.88 07/31/2025 M 256,046 (15) 05/28/2029 Common Stock 256,046 $0 7,805,447 D
Explanation of Responses:
1. The exercise and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025.
2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.
3. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $225.000 to $225.970, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
4. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $226.020 to $227.010, inclusive.
5. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $227.020 to $228.000, inclusive.
6. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $228.020 to $229.000, inclusive.
7. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $229.075 to $229.180, inclusive.
8. The shares are held by Invisible Hand Ventures, LLC, of which the Reporting Person is the manager and has sole voting and dispositive power.
9. The shares are held by the Slootman Family Foundation dated 11/24/2010 for which the Reporting Person is deemed to have voting and investment power over the shares held by the Slootman Family Foundation, but has no personal pecuniary interest in these shares.
10. The shares are held by the Slootman Living Trust dated 9/8/1999 for which the Reporting Person is a trustee.
11. The shares are held by the Slootman 2023 Grantor Retained Annuity Trust dated 9/25/23 for which the Reporting Person is a trustee.
12. The shares are held by the F. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person is the trustee.
13. The shares are held by the B. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person's spouse is the trustee.
14. The shares are held by the Slootman Grandchildren's Trust dated 7/28/2022 for which the Reporting Person is a trustee.
15. The stock option is fully vested.
Remarks:
/s/ Marie Reider, Attorney-in-Fact 08/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Cyclacel (CYCC) shares did David E. Lazar sell?

He sold 6,750 common shares on 07/30/25.

At what price were the CYCC shares sold?

The reported sale price was $12.36 per share.

What is Lazar’s remaining stake in Cyclacel after the sale?

He now owns 155,838 common shares directly.

Why does this Form 4 constitute an exit filing?

Because the sale dropped Lazar’s ownership below 10%, ending his obligation to file under Section 16.

How did the 1-for-15 reverse stock split affect the share numbers?

All holdings were proportionally reduced; prior preferred shares converted into 162,588 common shares post-split.
Snowflake Inc

NYSE:SNOW

SNOW Rankings

SNOW Latest News

SNOW Latest SEC Filings

SNOW Stock Data

68.41B
319.54M
4.08%
67.79%
3.14%
Software - Application
Services-prepackaged Software
Link
United States
BOZEMAN